Next Article in Journal
Sociodemographic Determinants, Health Conditions, and Mental Status as Predictors of the Functional Status of Older Saudi People
Previous Article in Journal
Multimorbidity and Anxiety Symptoms among Adults Aged 50 Years and Over from Six Low- and Middle-Income Countries
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan

1
Department of Health and Welfare Services, National Institute of Public Health, Wako, Saitama 351-0197, Japan
2
Department of Ophthalmology, Juntendo University School of Medicine, Tokyo 113-8431, Japan
3
The University of Fukuchiyama, Kyoto 620-0886, Japan
*
Author to whom correspondence should be addressed.
J. Ageing Longev. 2021, 1(1), 48-59; https://doi.org/10.3390/jal1010006
Submission received: 12 October 2021 / Revised: 28 November 2021 / Accepted: 29 November 2021 / Published: 8 December 2021

Abstract

:
The prevalence of dementia is rapidly increasing worldwide, and its treatment and prevention are a health concern. The prevention of dementia requires the identification of risk factors through longitudinal studies of lifestyle. In this study, we aimed to identify the risk factors for the development of dementia in Japan and to clarify their primary care strategies. We analyzed the relationship between the cognitive ability level determined by the survey of long-term care certification and the past questionnaire results of a specific health examination in Japan 10 years ago. To analyze the risk factors for developing dementia, multivariate analysis was used, which showed that residents who gained more than 10 kg since reaching 20 years of age had a significantly lower risk of developing dementia. Regarding the “start of lifestyle modifications” question, those who answered “already started” had a significantly lower risk than those who answered “no plan to improve”. Conversely, residents receiving insulin injections or oral hypoglycemic agents were at a significantly higher risk of developing dementia based on the results of the questionnaire of the health checkups surveyed 10 years prior.

1. Introduction

The prevalence of dementia is rapidly increasing worldwide, and its treatment and prevention are a health concern [1]. According to the WHO, the number of people with dementia was estimated at 36 million in 2012 [2]. In addition, the G8 dementia summit reports that the number of patients afflicted with dementia worldwide will double in 20 years, from 66 million in 2030 to 115 million in 2050 [3]. According to a general research report on the future estimates of the elderly population with dementia by a research group of the Ministry of Health, Labor, and Welfare (MHLW) of Japan, 4.62 million people suffered from dementia in 2013, with a future estimate of 6.75 million in 2025 and 8.2 million in 2030 [4].
The risk of developing dementia increases with age and increases in people over the age of 70–75. Dementia imposes a heavy burden on both the patients and their families. Therefore, there is an urgent need to establish effective and standard preventive measures for dementia. As with other adult diseases, risk factors for dementia must first be identified in order to establish effective preventive measures. Disease prevention can be divided into three stages: “primary prevention”, “secondary prevention”, and “tertiary prevention”. In order to decrease the incidence of dementia, it is necessary for society as a whole to work on “primary prevention” and “secondary prevention”. This requires longitudinal cohort studies of people’s lifestyle and health status to identify risk factors. Among lifestyle-related diseases, metabolic syndrome in middle-aged individuals and diabetes in the elderly are known to be risk factors for dementia. Metabolic syndrome has been reported to be associated with an increased incidence of dementia progression [5]. In addition, diabetes has been reported as a risk factor for cognitive impairment [6,7,8,9,10,11]. There are several different studies on the association between middle-aged obesity and the development of dementia. A meta-analysis also reported an increased risk of dementia due to middle-aged obesity; however, the correlation between being underweight and dementia is controversial [12]. A meta-analysis further suggested that middle-aged obesity is positively associated with subsequent dementia. However, the effect of weight loss among middle-aged people on the risk of developing cognitive ability is unclear [13].
Weight loss in cases of dementia begins before cognitive decline and accelerates the pace of weight loss at the time of definitive diagnosis [14]. Previous epidemiological studies have suggested that dementia can cause involuntary weight loss before the onset of its clinical symptoms, and that weight loss may appear to be a risk factor for dementia [15,16,17]. However, the covariates in the statistical models of past studies differed significantly between studies. Consequently, some factors, such as diabetes, depression, high blood pressure, and stroke, can confound or disrupt the link between body mass index (BMI) and dementia [13]. Therefore, in order to analyze whether weight loss is a risk factor for dementia, multivariate analysis including medical records should be performed. In Japan, Yokomichi et al. suggested that being underweight and having diabetes are risk factors among the elderly for the incidence of dementia, and that lower BMI is also associated with the incidence of dementia [18]. In our previous study, abdominal circumference was a risk factor for dementia in an analysis that considered body weight, BMI, medical records, and various biochemical test results as confounding factors [19]. Therefore, it is important to analyze the effect of body weight on the incidence of dementia based on ethnicity and food culture [18].
On the other hand, it has been reported that dementia may also occur due to a potentially correctable risk factor, namely, lack of exercise [20], and disease prevention can be achieved through engaging in exercise. From human and animal studies, it was found that exercise may stimulate improvements in cerebrovascular function, perfusion, and neuroplasticity in the brain and may prevent progressive loss of cognitive function [21,22]. However, the causal relationship between cognitive function and exercise remains ambiguous in the elderly [23,24]. In addition, some randomized controlled trials analyzing the effects of exercise on dementia have shown inconsistent results [25,26,27,28,29,30,31,32]. Although studies on the effects of exercise on dementia patients have been reported, there are few studies on whether lack of exercise is a risk factor for the incidence of dementia in healthy subjects.
In 2008, the MHLW of Japan launched a specific health checkup policy to screen high-risk groups for metabolic syndrome. This health checkup/guidance policy is a national health program to prevent metabolic syndrome, encourage lifestyle-related interventions, and reduce medium- to long-term social security costs [33]. This specific health check consists of 30 items, including biochemical tests and a 24-item questionnaire. In addition, all people over the age of 40 are obliged to take out long-term care insurance in Japan. Residents in need of long-term care are provided with long-term care services at home and in institutions [34]. Municipalities provide various long-term care services with insurance to residents in need of long-term care [35]. When residents apply for nurse care, the Municipal Needs Certification Committee promptly investigates more than 70 functions, such as daily living function, cognitive function, physical function, living function, adaptation to society, and behavioral disorder. The level of care required is classified into seven tiers (support needs two stages, care needs five stages) [36]. The data from this Municipal Care Certification Survey include items related to dementia, where doctors measure the cognitive ability level in the subject.
The purpose of this study was to analyze the correlation between the cognitive ability level of the municipal investigation and the results of the past questionnaire on specific health checkups, and to evaluate risk factors for the development of dementia in Japan.

2. Materials and Methods

2.1. Study Population

The subjects included in this survey were insured individuals (population: 107,000) in Mishima City, Japan. A total of 606 people (207 men and 399 women; average age: 79.53 ± 4.27 years, 55–84 years) who received long-term care services, including a doctor’s diagnosis of dementia in 2018 and a standard health examination program in 2008, were included. Individuals who were already diagnosed with dementia in 2008 were excluded from this study. The study’s screening program was offered to people belonging to the insured community, over the age of 40, in 2008. The test consisted of 28 physical examinations, a laboratory examination, and a 24-item questionnaire.

2.2. Classification of Cognitive Ability Level

Doctors examine the core and the peripheral symptoms of dementia. To assess short-term memory, for example, they show patients three things that are very familiar to them. The things are put away, and five minutes later, the doctors ask questions about the three things to evaluate the patient’s short-term memory ability. The ability to communicate intentions is evaluated on a four-point scale: can be communicated, can be communicated with some difficulty, only specific requests can be communicated, and cannot be communicated. In addition, doctors assess the peripheral symptoms of dementia for hallucinations, auditory hallucinations, delusions, day/night reversals, abuse, assault, resistance to long-term care, and wandering behavior. At the same time, the long-term care specialist evaluates the patient’s cognitive function (9 items), mental/behavioral disorders (15 items), and adaptation to social life (6 items). Based on these diagnoses, doctors evaluate the cognitive ability level of patients in making daily decisions on a four-point scale: (1) can make on their own, (2) have some difficulty, (3) need support, and (4) have little ability.

2.3. Statistical Analysis

Lifestyles affecting the incidence of dementia were evaluated using a logistic regression analysis. To exclude confounding factors, multiple logistic regression analysis was performed and adjusted odds ratios (OR) were calculated. Prior to the analysis, individuals were divided into two categories, (I, II) and (III, IV), on the basis of their cognitive ability. Multivariate logistic regression analysis included cognitive ability levels (III-IV/I–II) as the dependent variable and the results of a specific health questionnaire as the independent variable (age, gender, medical history, drug intake status and lifestyle, and outpatient medical expenses). The above statistical analysis was based on SPSS ver26 (IBM Corp., Armonk, NY, USA) and Modeler ver 18.2 (IBM Corp., Armonk, NY, USA). This study was approved by the Institutional Review Board (NIPH-IBRA # 12137) of the National Institute of Public Health in Japan and the Mishima City Council. This study was conducted in accordance with the International Epidemiological Ethics Guidelines [37], Guidelines for Using the National Health Insurance Claim Database, Specific Health Examinations/Guidance [38], and Health Information System Security Guidelines [39]. Following the steps in these guidelines, researchers performed the analysis after individual data were anonymized by the municipality.

3. Results

Figure 1 shows the classification results of cognitive ability level in daily life (2018). Approximately 36.3% of residents were classified as cognitive ability level III or higher.
Table 1 shows the results of the cross-tabulation of the questionnaires conducted in 2008 and the cognitive ability level. As a result of the cross tabulation, significant differences were found in the items “heart disease history” and “anemia history”.
First, a univariate logistic analysis was performed to determine the crude odds ratio, and significant crude odds ratios were obtained for the two items, “weight gain of more than 10 kg since 20 years old” and “start of lifestyle modifications” (Table 2). Subsequently, multivariate logistic regression analysis was performed to eliminate confounding factors and investigate risk factors for the development of dementia, and a significant OR was observed for the development of dementia in three items, including “insulin injection or hypoglycemic medications (Yes/No)”, “weight gain of more than 10 kg since 20 years old”, and “start of lifestyle modifications” (Table 2). Residents who received oral hypoglycemic drug or insulin injection were at a significantly higher risk of developing dementia (OR: 1.713, 95% CI: 1.048–2.798). Residents who gained more than 10 kg since reaching 20 years of age had a significantly lower risk of developing dementia (OR: 0.623, 95% CI: 0.415–0.935) (Table 2). Regarding the “start of lifestyle modifications” item, those who answered “already started (<6 months ago)” or “already started (≥6 months ago)” had a significantly lower risk than those who answered “no plan to improve”. No significant OR was obtained for other lifestyle or dietary items, medical history, or outpatient medical expenditures in 2008 (Table 2).

4. Discussion

The number of residents certified as requiring long-term care in Japan increased from 2.18 million at the end of 2000, when the long-term care insurance system was established, to 6.68 million at the end of 2020 [35]. In order to receive these care services, residents must apply for long-term care qualifications in the area and undergo a long-term care certification survey. In this nurse care survey, doctors and nurse care reviewers assess the physical and mental condition of the applicant and identify the type of care required. The results of this accreditation survey are used to assess the level of care required by all Japanese residents. The data investigated in this review are collected nationwide and continue to accumulate in a large database. This database is expected to help identify risk factors for the incidence of dementia and to clarify primary care policies.
In Japan, specific health examinations and health guidance to prevent metabolic syndrome were initiated in 2008 [40]. The National Health Insurance Claims Database for this specific medical checkup shows that there is a difference in annual medical costs between those who have been screened for metabolic syndrome reserves and those who have not [41]. Based on the results of these health examinations, residents who require specific health guidance according to the risk can be classified as requiring one of three levels of support. Specific health guidance will guide the improved lifestyle-related risks, such as eating habits and exercise habits, and if the risk factors for the development of dementia can be identified from the collected results of this specific health checkup, these systems may be able to provide support to prevent the risk of dementia as well as metabolic syndrome. In this study, lifestyle risk factors were identified by matching a specific health checkup questionnaire with long-term care certification 10 years later.
The results of this study showed that those who answered “weight gain of more than 10 kg since 20 years old” had a lower risk of dementia. Qizilbash N et al. reported that being underweight after middle age increased the risk of dementia over the next 20 years [42]. Nam GE et al. reported that a decreased baseline BMI has been associated with an increased risk of dementia of all causes, and weight loss was also reported to be significantly associated with the risk of developing dementia [43]. On the other hand, Kivimäki M et al. reported that higher BMI was an important risk factor for dementia if BMI was detected more than twenty years before the onset of dementia. However, they reported that a low BMI was a significant risk factor for dementia if measured within ten years of diagnosis [44]. In Japan, women with high blood pressure and low weight and men with dyslipidemia and low weight have been reported to be at increased risk of developing dementia. [14]. In our previous study, we performed a multivariate analysis by adding abdominal circumference simultaneously as an independent variable with BMI and body weight. We did not obtain a significant OR for BMI and body weight, but a significant OR was obtained for abdominal circumference [19]. Few studies have examined the association between abdominal circumference and the development of dementia, and further studies using multivariate analysis using abdominal circumference, body weight, and BMI simultaneously as independent variables are needed in the future.
Although previous studies have reported the effects of physical exercise on cognitive function [8,9,10], the results for people with dementia have been inconsistent [11,12]. In addition, there are few studies on whether lack of exercise in healthy people affects the development of dementia in the future. In this study, no significant OR was obtained for exercise-related lifestyle habits, such as “exercising for 30 min or more, 2 days or more every week” and “walking more than 1 h daily” reported in the survey 10 years prior.
On the other hand, residents who answered “already started” when asked about “start of lifestyle modifications” had a significantly lower risk of developing dementia. Therefore, providing guidance to increase the motivation for lifestyle-related improvements in specific health guidance can be effective.
In this study, individuals taking insulin injections or oral hypoglycemic agents were at an increased risk of developing dementia. Hirabayashi et al. have reported that diabetes is a risk factor for dementia, and hippocampal atrophy with the progression of diabetes has been reported to occur especially in patients with long-term illness [45,46,47]. The results of this study are consistent with the results of these previous reports.
In the future, to prevent the onset of dementia in Japan, it is necessary to clarify more accurate risks, such as lifestyle-related diseases. If the risk of developing dementia becomes clear, it is possible that specific health examinations and guidance already being implemented in Japan to prevent metabolic syndrome can also be used to prevent dementia. Therefore, in the future, larger samples and long-term studies are needed to identify specific health care items related to the risk of dementia.

5. Conclusions

The results of this study suggest that those who have been prescribed insulin injections or hypoglycemic agents have an increased risk of dementia based on the questionnaire-specific health checkups. In contrast, those who gained more than 10 kg since reaching 20 years of age and those who answered “already started to improve” in the question regarding the “start of lifestyle modifications” had a lower risk 10 years after the first survey. Further long-term studies using larger samples are needed to identify specific health care items that screen for the risk of developing dementia.

Author Contributions

Conceptualization, Y.T. and T.K.; methodology, Y.T. and Y.H.; investigation, Y.T.; formal analysis, Y.T.; writing—original draft preparation, Y.T., Y.H. and T.K.; writing—review and editing, Y.T., Y.H. and T.K.; supervision, T.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from MEXT/JSPS KAKENHI (JP21K02001).

Institutional Review Board Statement

This study was approved by the Institutional Review Board (NIPH-IBRA # 12137) of the National Institute of Public Health in Japan and the Mishima City Council.

Informed Consent Statement

The data used in this study was anonymous data with personal information removed by the municipality. In Japan, the national data of medical receipts and specific medical examinations can be used for academic research with high public interest for purposes other than the original purpose without the consent of the residents. (24 December 2010 Minister of Health, Labor and Welfare Notification No. 424).

Data Availability Statement

To protect the participants’ anonymity, the data will not be shared unless requested through an administrative procedure.

Conflicts of Interest

All authors report no conflict of interest related to this work.

References

  1. Alladi, S.; Hachinski, V. World dementia: One approach does not fit all. Neurology 2018, 91, 264–270. [Google Scholar] [CrossRef] [PubMed]
  2. World Health Organization; Alzheimer’s Disease International. Dementia: A Public Health Priority; WHO Press: Geneva, Switzerland, 2012. [Google Scholar]
  3. Department of Health and Social Care; Foreign & Commonwealth Office; Prime Minister’s Office; The Rt Hon Jeremy Hunt MP. UK to host G8 dementia summit. Clin. Pharm. 2013. [Google Scholar] [CrossRef]
  4. Ninomiya, T. General Research Report to the Future Estimation of the Elderly Population of the Dementia of a Japanese. Available online: https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201405037A (accessed on 12 October 2021).
  5. Keang, L.T.; Feng, L.; Nyunt, M.S.; Feng, L.; Gao, Q.; Lim, M.L.; Collinson, S.L.; Chong, M.S.; Lim, W.S.; Lee, T.-S.; et al. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia. JAMA Neurol. 2016, 73, 456–463. [Google Scholar] [CrossRef] [Green Version]
  6. Biessels, G.J.; Staekenborg, S.; Brunner, E.; Brayne, C.; Scheltens, P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol. 2006, 5, 64–74. [Google Scholar] [CrossRef]
  7. Katon, W.; Lin, E.H.B.; Williams, L.H.; Ciechanowski, P.; Heckbert, S.R.; Ludman, E.; Rutter, C.; Crane, P.K.; Oliver, M.; Von Korff, M. Comorbid Depression Is Associated with an Increased Risk of Dementia Diagnosis in Patients with Diabetes: A Prospective Cohort Study. J. Gen. Intern. Med. 2010, 25, 423–429. [Google Scholar] [CrossRef] [Green Version]
  8. Ma, F.; Wu, T.; Miao, R.; Xiao, Y.Y.; Zhang, W.; Huang, G. Conversion of Mild Cognitive Impairment to Dementia among Subjects with Diabetes: A Population-Based Study of Incidence and Risk Factors with Five Years of Follow-up. J. Alzheimer’s Dis. 2014, 43, 1441–1449. [Google Scholar] [CrossRef] [PubMed]
  9. Ninomiya, T. Epidemiological Evidence of the Relationship between Diabetes and Dementia. Single Mol. Single Cell Seq. 2019, 1128, 13–25. [Google Scholar] [CrossRef]
  10. Bello-Chavolla, O.Y.; Antonio-Villa, N.E.; Vargas-Vázquez, A.; Ávila-Funes, J.A.; Aguilar-Salinas, C.A. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research. Curr. Diabetes Rev. 2019, 15, 456–470. [Google Scholar] [CrossRef] [PubMed]
  11. Yokomichi, H.; Nagai, A.; Hirata, M.; Kiyohara, Y.; Muto, K.; Ninomiya, T.; Matsuda, K.; Kamatani, Y.; Tamakoshi, A.; Kubo, M.; et al. Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan. J. Epidemiol. 2017, 27, S92–S97. [Google Scholar] [CrossRef] [PubMed]
  12. Albanese, E.; Launer, L.J.; Egger, M.; Prince, M.J.; Giannakopoulos, P.; Wolters, F.J.; Egan, K. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2017, 8, 165–178. [Google Scholar] [CrossRef]
  13. Pedditizi, E.; Peters, R.; Beckett, N. The risk of overweight/obesity in mid-life and late life for the development of dementia: A systematic review and meta-analysis of longitudinal studies. Age Ageing 2016, 45, 14–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Stewart, R.; Masaki, K.; Xue, Q.-L.; Peila, R.; Petrovitch, H.; White, L.R.; Launer, L.J. A 32-Year Prospective Study of Change in Body Weight and Incident Dementia. Arch. Neurol. 2005, 62, 55–60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Buchman, A.S.; Schneider, J.A.; Wilson, R.S.; Bienias, J.L.; Bennett, D.A. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 2006, 67, 1949–1954. [Google Scholar] [CrossRef]
  16. Johnson, D.K.; Wilkins, C.H.; Morris, J.C. Accelerated Weight Loss May Precede Diagnosis in Alzheimer Disease. Arch. Neurol. 2006, 63, 1312–1317. [Google Scholar] [CrossRef] [PubMed]
  17. Van der Burg, J.M.; Pijl, H.; Campman, Y.J.; Roos, R.A.; Aziz, N.A. Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol. 2015, 3, 499–500. [Google Scholar] [CrossRef]
  18. Yokomichi, H.; Kondo, K.; Nagamine, Y.; Yamagata, Z.; Kondo, N. Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study. J. Diabetes Investig. 2019, 11, 206–215. [Google Scholar] [CrossRef] [PubMed]
  19. Tamaki, Y.; Hiratsuka, Y.; Kumakawa, T. Risk Factors for Dementia Incidence Based on Previous Results of the Specific Health Checkups in Japan. Healthcare 2020, 8, 491. [Google Scholar] [CrossRef]
  20. Norton, S.; Matthews, F.E.; Barnes, D.E.; Yaffe, K.; Brayne, C. Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol. 2014, 13, 788–794. [Google Scholar] [CrossRef] [Green Version]
  21. Erickson, K.I.; Weinstein, A.M.; Lopez, O.L. Physical activity, brain plasticity, and Alzheimer’s disease. Arch. Med. Res. 2012, 43, 615–621. [Google Scholar] [CrossRef] [Green Version]
  22. Davenport, M.H.; Hogan, D.B.; Eskes, G.A.; Longman, R.S.; Poulin, M.J. Cerebrovascular reserve: The link betweenfitness and cognitive function? Exerc. Sport Sci. Rev. 2012, 40, 153–158. [Google Scholar] [CrossRef] [PubMed]
  23. Sink, K.M.; Espeland, M.A.; Castro, C.M.; Church, T.; Cohen, R.; Dodson, J.A.; Guralnik, J.; Hendrie, H.C.; Jennings, J.; Katula, J.; et al. Effect of a 24-month physical activity intervention vs health education on cognitive outcomes in sedentary older adults: The LIFE randomized trial. JAMA 2015, 314, 781–790. [Google Scholar] [CrossRef]
  24. Young, J.; Angevaren, M.; Rusted, J.; Tabet, N. Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst. Rev. 2015, 4, CD005381. [Google Scholar] [CrossRef] [PubMed]
  25. Forbes, D.; Forbes, S.C.; Blake, C.M.; Thiessen, E.J.; Forbes, S. Exercise programs for people with dementia. Cochrane Database Syst. Rev. 2015, 4, CD006489. [Google Scholar] [CrossRef] [Green Version]
  26. Toots, A.; Littbrand, H.; Boström, G.; Hörnsten, C.; Holmberg, H.; Lundin-Olsson, L.; Lindelöf, N.; Nordström, P.; Gustafson, Y.; Rosendahl, E. Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial. J. Alzheimer’s Dis. 2017, 60, 323–332. [Google Scholar] [CrossRef] [Green Version]
  27. Bossers, W.J.; van der Woude, L.H.; Boersma, F.; Hortobagyi, T.; Scherder, E.J.; van Heuvelen, M.J. A 9-week aerobic and strength training program improves cognitive and motor function in patients with dementia: A randomized, controlled trial. Am. J. Geriatr. Psychiatry 2015, 23, 1106–1116. [Google Scholar] [CrossRef] [PubMed]
  28. Telenius, E.W.; Engedal, K.; Bergland, A. Effect of a high-intensity exercise program on physical function and mental health in nursing home residents with dementia: An assessor blinded randomized controlled trial. PLoS ONE 2015, 10, e0126102. [Google Scholar] [CrossRef] [Green Version]
  29. Arcoverde, C.; Deslandes, A.; Moraes, H.; Almeida, C.; de Araujo, N.B.; Vasques, P.E.; Silveira, H.; Laks, J. Treadmill training as an augmentation treatment for Alzheimer’s disease: A pilot randomized controlled study. Arq. De Neuro-Psiquiatr. 2014, 72, 190–196. [Google Scholar] [CrossRef] [Green Version]
  30. Öhman, H.; Savikko, N.; Strandberg, T.E.; Kautiainen, H.; Raivio, M.M.; Laakkonen, M.L.; Tilvis, R.; Pitkälä, K.H. Effects of exercise on cognition: The Finnish Alzheimer disease exercise trial: A randomized, controlled trial. J. Am. Geriatr. Soc. 2016, 64, 731–738. [Google Scholar] [CrossRef]
  31. Cancela, J.M.; Ayan, C.; Varela, S.; Seijo, M. Effects of a long-term aerobic exercise intervention on institutionalized patients with dementia. J. Sci. Med. Sport 2016, 19, 293–298. [Google Scholar] [CrossRef] [PubMed]
  32. Kemoun, G.; Thibaud, M.; Roumagne, N.; Carette, P.; Albinet, C.; Toussaint, L.; Paccalin, M.; Dugue, B. Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dement. Geriatr. Cogn. Disord. 2010, 29, 109–114. [Google Scholar] [CrossRef] [PubMed]
  33. Tamaki, Y.; Okamoto, E.; Hiratsuka, Y.; Kumakawa, T. Influence of Specific Health Guidance on the Consultation Rate of Metabolic-Related Diseases. Adv. Public Health 2019, 2019, 9735127. [Google Scholar] [CrossRef]
  34. Japanese Ministry of Health, Labour and Welfare. Long-Term Care, Health and Welfare Services for the Elderly. Available online: http://www.mhlw.go.jp/english/policy/care-welfare/care-welfare-elderly/ (accessed on 12 October 2021).
  35. Japanese Ministry of Health, Labour and Welfare. “Long-Term Care Insurance Business Situation”. Available online: https://www.mhlw.go.jp/topics/kaigo/toukei/joukyou.html (accessed on 12 October 2021).
  36. Tamaki, Y.; Hiratsuka, Y.; Kumakawa, T.; Miura, H. Relationship between the Necessary Support Level for Oral Hygiene and Performance of Physical, Daily Activity, and Cognitive Functions. Int. J. Dent. 2018, 2018, 1542713. [Google Scholar] [CrossRef] [Green Version]
  37. Japanese Ministry of Health, Labour and Welfare. Ethical Guidelines for Epidemiological Research. Ministry of Education, Culture, Sports, Science and Technology. Available online: http://www.lifescience.mext.go.jp/files/pdf/n796_01.pdf (accessed on 12 October 2021).
  38. Japanese Ministry of Health, Labour and Welfare. Guideline for Provision of Database for National Health Insurance Claim and the Specific Medical Checkup and Specific Health Guidance. Available online: http://www.mhlw.go.jp/file/05-Shingikai-12401000-Hokenkyoku-Soumuka/0000064238_3.pdf (accessed on 12 October 2021).
  39. Japanese Ministry of Health, Labour and Welfare. Security Guidelines for Health Information Systems. Available online: http://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000166260.pdf (accessed on 12 October 2021).
  40. Okamoto, E. Cost-Benefit of Health Promotion: Will It Pay Off? Japan’s Venture against Metabolic Syndrome. Asian Perspect. Evid. Health Promot. Educ. 2011, 182–195. [Google Scholar] [CrossRef]
  41. Japanese Ministry of Health, Labour and Welfare. Estimated Medical Cost Database. Available online: http://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken03/01.html (accessed on 12 October 2021).
  42. Qizilbash, N.; Gregson, J.; Johnson, M.E.; Pearce, N.; Douglas, I.J.; Wing, K.; Evans, S.J.W.; Pocock, S.J. BMI and risk of dementia in two million people over two decades: A retrospective cohort study. Lancet Diabetes Endocrinol. 2015, 3, 431–436. [Google Scholar] [CrossRef]
  43. Nam, G.E.; Park, Y.G.; Han, K.; Kim, M.K.; Koh, E.S.; Kim, E.S.; Lee, M.-K.; Kim, B.; Hong, O.-K.; Kwon, H.-S. BMI, Weight Change, and Dementia Risk in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study. Diabetes Care 2019, 42, 1217–1224. [Google Scholar] [CrossRef] [PubMed]
  44. Kivimäki, M.; Luukkonen, R.; Batty, G.D.; Ferrie, J.E.; Pentti, J.; Nyberg, S.T.; Shipley, M.J.; Alfredsson, L.; Fransson, E.I.; Goldberg, M.; et al. Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals. Alzheimer’s Dement. 2018, 14, 601–609. [Google Scholar] [CrossRef]
  45. Hirabayashi, N.; Hata, J.; Ohara, T.; Mukai, N.; Nagata, M.; Shibata, M.; Gotoh, S.; Furuta, Y.; Yamashita, F.; Yoshihara, K.; et al. Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: The Hisayama Study. Diabetes Care 2016, 39, 1543–1549. [Google Scholar] [CrossRef] [Green Version]
  46. Matsuzaki, T.; Sasaki, K.; Tanizaki, Y.; Hata, J.; Fujimi, K.; Matsui, Y.; Sekita, A.; Suzuki, S.O.; Kanba, S.; Kiyohara, Y.; et al. Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study. Neurology 2010, 75, 764–770. [Google Scholar] [CrossRef]
  47. Ohara, T.; Doi, Y.; Ninomiya, T.; Hirakawa, Y.; Hata, J.; Iwaki, T.; Kanba, S.; Kiyohara, Y. Glucose tolerance status and risk of dementia in the community: The Hisayama Study. Neurology 2011, 77, 1126–1134. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Result of cognitive level in making daily decisions (2018).
Figure 1. Result of cognitive level in making daily decisions (2018).
Jal 01 00006 g001
Table 1. The results of the cross-tabulation of questionnaires conducted in 2008 and the cognitive ability level in daily life.
Table 1. The results of the cross-tabulation of questionnaires conducted in 2008 and the cognitive ability level in daily life.
Cognitive Ability Level in Daily Life
Can Make on Their OwnHave Some DifficultyNeed Support Have Little AbilityTotalp-Value
A medicine to lower blood pressure Yes1139668413180.704
35.5%30.2%21.4%12.9%100.0%
No97806645288
33.7%27.8%22.9%15.6%100.0%
Insulin injections or a medicine to lower blood glucose Yes27262813940.243
28.7%27.7%29.8%13.8%100.0%
No18315010673512
35.7%29.3%20.7%14.3%100.0%
A medicine to lower cholesterol Yes644943191750.399
36.6%28.0%24.6%10.9%100.0%
No1461279167431
33.9%29.5%21.1%15.5%100.0%
Stroke historyYes27201311710.824
38.0%28.2%18.3%15.5%100.0%
No18315612175535
34.2%29.2%22.6%14.0%100.0%
Heart disease historyYes2322192660.037
34.8%33.3%28.8%3.0%100.0%
No18715411584540
34.6%28.5%21.3%15.6%100.0%
Chronic renal failure history Yes010010.485
0.0%100.0%0.0%0.0%100.0%
No21017513486605
34.7%28.9%22.1%14.2%100.0%
Anemia historyYes3818176790.033
48.1%22.8%21.5%7.6%100.0%
No17215811780527
32.6%30.0%22.2%15.2%100.0%
Current regular smokerYes2717198710.521
38.0%23.9%26.8%11.3%100.0%
No18,300.0%15,900.0%11,500.0%7800.0%53,500.0%
34.2%29.7%21.5%14.6%100.0%
Weight gained more than 10 kg since 20 years old Yes776638232040.136
37.7%32.4%18.6%11.3%100.0%
No1331109663402
33.1%27.4%23.9%15.7%100.0%
Exercising for 30 min or more, 2 days or more every week Yes927859352640.995
34.8%29.5%22.3%13.3%100.0%
No118987551342
34.5%28.7%21.9%14.9%100.0%
Walking more than 1 h everyday Yes1089268413090.916
35.0%29.8%22.0%13.3%100.0%
No102846645297
34.3%28.3%22.2%15.2%100.0%
Walk faster than people of your age and sex Yes855957382390.259
35.6%24.7%23.8%15.9%100.0%
No1251177748367
34.1%31.9%21.0%13.1%100.0%
Weight gain or loss of more than 3kg over the last year Yes455739211620.089
27.8%35.2%24.1%13.0%100.0%
No1651199565444
37.2%26.8%21.4%14.6%100.0%
Eating pace Faster1820199660.546
27.3%30.3%28.8%13.6%100.0%
Normal1521198664421
36.1%28.3%20.4%15.2%100.0%
Slower40372913119
33.6%31.1%24.4%10.9%100.0%
Evening meal within 2 h before going to bed Yes2624159740.870
35.1%32.4%20.3%12.2%100.0%
No18415211977532
34.6%28.6%22.4%14.5%100.0%
Have snack after the evening meal Yes1617145520.584
30.8%32.7%26.9%9.6%100.0%
No19415912081554
35.0%28.7%21.7%14.6%100.0%
Skip breakfast 3 days
or more per week
Yes121056330.752
36.4%30.3%15.2%18.2%100.0%
No19816612980573
34.6%29.0%22.5%14.0%100.0%
Drink alcohol Rarely (can’t drink)33242115930.832
35.5%25.8%22.6%16.1%100.0%
Sometimes3633201099
36.4%33.3%20.2%10.1%100.0%
Everyday1411199361414
34.1%28.7%22.5%14.7%100.0%
Feel refreshed after a night’s sleep Yes16112498674500.448
35.8%27.6%21.8%14.9%100.0%
No49523619156
31.4%33.3%23.1%12.2%100.0%
Start lifestyle
modifications
no plan to improve404123101140.10
35.1%36.0%20.2%8.8%100.0%
going to start in the future (within 6 months)23176652
44.2%32.7%11.5%11.5%100.0%
going to start soon
(in a month)
211991160
35.0%31.7%15.0%18.3%100.0%
already started
(<6 months ago)
60474220169
35.5%27.8%24.9%11.8%100.0%
already started
(≥6 months ago)
66525439211
31.3%24.6%25.6%18.5%100.0%
Willing to have Health Guidance Yes1138769343030.163
37.3%28.7%22.8%11.2%100.0%
No97896552303
32.0%29.4%21.5%17.2%100.0%
Total21017613486606
34.7%29.0%22.1%14.2%100.0%
p-value: Chi-square test.
Table 2. Results of logistic regression analysis.
Table 2. Results of logistic regression analysis.
Item Crude Odds Ratio95% CIp-ValueMultivariate Adjusted Odds Ratio95% CIp-Value
Lower LimitUpper Limit Lower LimitUpper Limit
Ageyears1.0260.9861.0680.2111.0170.9741.0620.443
Sex(Female/Male)0.9140.6451.2940.6120.9500.6011.5020.826
A medicine to lower blood pressure (Yes/No)0.8320.5971.1590.2760.8320.5731.2070.332
Insulin injections or a medicine to lower blood glucose (Yes/No)1.4390.9212.2490.1101.7131.0482.7980.032
A medicine to lower cholesterol (Yes/No)0.9480.6571.3680.7751.1550.7691.7370.487
Stroke history(Yes/No)0.8830.5241.4890.6410.9510.5311.7040.865
Heart disease history(Yes/No)0.8000.4631.3810.4230.9720.5331.7710.925
Chronic renal failure history (Yes/No)0.0000.000 1.0000.0000.000 1.000
Anemia history(Yes/No)0.6880.4101.1530.1560.6530.3771.1330.130
Current regular smoker(Yes/No)1.0870.6531.8120.7480.9950.5661.7490.987
Weight gained more than 10 kg since 20 years old (Yes/No)0.6520.4550.9350.0200.6230.4150.9350.022
Exercising for 30 min or more, 2 days or more every week (Yes/No)0.9480.6791.3240.7540.8930.6041.3200.570
Walking more than 1 h everyday (Yes/No)0.9130.6561.2720.5910.8670.5871.2820.475
Walk faster than people of your age and sex (Yes/No)1.2770.9121.7890.1551.4180.9702.0730.072
Weight gain or loss of more than 3kg over the last year 1.0440.7191.5160.8211.2940.8541.9620.224
Eating pace
   Normal
Reference Group
   Faster 1.0150.6631.5530.9460.8740.5491.3940.573
   Slower 1.3510.7302.5020.3391.4640.7542.8420.260
Evening meal within 2 h before going to bed (Yes/No)0.8230.4901.3810.4600.7850.4401.4000.412
Have snack after the evening meal (Yes/No)1.0110.5601.8250.9711.2150.6402.3050.552
Skip breakfast 3 days or more per week (Yes/No)1.0110.5601.8250.9710.8620.3841.9320.718
Drink alcohol
  Rarely (can’t drink)
Reference Group
  Sometimes 0.7340.4581.1780.2000.6530.3911.0920.104
  Everyday 1.0660.6721.6930.7861.1360.6342.0360.667
Feel refreshed after a night’s sleep (Yes/No)1.0630.7271.5550.7521.0910.7221.6500.679
Start lifestyle modifications
 no plan to improveReference Group
 going to start in the
future (within 6
months)
0.7350.4861.1130.1460.7020.4361.1300.145
 going to start soon
(in a month)
0.6340.3481.1580.1380.5780.2991.1170.103
 already started
(<6 months ago)
0.3810.1890.7670.0070.3350.1570.7140.005
 already started
(≥6 months ago)
0.5170.3170.8420.0080.4730.2740.8160.007
Willing to have Health Guidance (Yes/No)0.8190.5881.1410.2370.9690.6621.4190.873
Outpatient Medical
Expenditures (2008)
1.0001.0001.0000.6881.0001.0001.0000.456
_cons 0.336 0.508
Dependent variable was classified to (III,IV)/(I,II).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tamaki, Y.; Hiratsuka, Y.; Kumakawa, T. Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan. J. Ageing Longev. 2021, 1, 48-59. https://doi.org/10.3390/jal1010006

AMA Style

Tamaki Y, Hiratsuka Y, Kumakawa T. Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan. Journal of Ageing and Longevity. 2021; 1(1):48-59. https://doi.org/10.3390/jal1010006

Chicago/Turabian Style

Tamaki, Yoh, Yoshimune Hiratsuka, and Toshiro Kumakawa. 2021. "Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan" Journal of Ageing and Longevity 1, no. 1: 48-59. https://doi.org/10.3390/jal1010006

APA Style

Tamaki, Y., Hiratsuka, Y., & Kumakawa, T. (2021). Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan. Journal of Ageing and Longevity, 1(1), 48-59. https://doi.org/10.3390/jal1010006

Article Metrics

Back to TopTop